Innova Medical Group Inc. Considering that 1998, this CLIA-certified clinical lab has actually shown magnificent success in endocrinology, cytology, toxicology, and molecular studies. Most just recently BIOLAB played an essential role in COVID-19 molecular (RT-PCR )and antibody(IgM/IgG)testing with its 24-hour turnaround on all regular testing and 2-hour STAT results in emergency situation circumstances. BIOLAB is acknowledged by the American Association of Bioanalysts (AAB), the College of American Pathologists(CAP), and ranks as a Biosafety Level 2 High-Complexity Lab. BIOLAB’s around 130-employee medical team is consisted of medical physicians, clinical lab researchers, bioanalysts, pathologists, microbiologists, and analytical chemists. The business has its own internal logistics and medical billing division, with experience in all industrial and government insurance plans.
Located only 30 miles from downtown Los Angeles, California, BIOLAB has actually provided on-site testing services for the show business and has actually partnered with whole cities to evaluate vital employees for COVID-19. Just 15 miles from IMG’s latest production facility in Brea, California, this acquisition improves IMG’s end-to-end option as a medical device and services provider. IMG’s California footprint contributes to its tested existence as the world’s biggest maker of rapid antigen test packages.
“We are thrilled to become part of Innova Medical Group and thrilled about the considerable growth that this acquisition will bring to BIOLAB,” commented Jordan Wang, Handling Director, BIOLAB. “This growth is essential to our ability to assist the city of L.A. manage the COVID-19 crisis.”
Daniel Elliott, President and CEO of IMG, Inc. described, “Today’s acquisition of BIOLAB not only expands our R&D and clinical research study management capability in the U.S. but also our ability to provide diagnostic services at large-scale to both corporate and government clients. With BIOLAB, we increase our robust ability to provide diagnostic tests and to produce internal diagnostic services. As Innova continues to grow our portfolio, BIOLAB will also help to confirm our partner products.”
With the unmatched need for COVID-19 testing, manufacturers need to fortify supply chains to secure the schedule of collection devices, assay reagents, and packages. IMG presently ships higher than 4 million rapid antigen test packages per day and expects to double that volume by year-end. Including a CLIA lab to IMG’s portfolio simplifies testing workflows with precise and inexpensive processing. BIOLAB’s years of gotten experience and used understanding matches IMG’s ability to develop options for deadly illness.
IMG prepares to significantly expand BIOLAB’s testing capability into 2021. BIOLAB will relocate to its new location in Pomona, Calif., in early 2021, including around 100 new jobs to the area.
Media Inquiries: Contact [email secured] About Innova Medical Group, Inc. Innova Medical Group, Inc. (IMG)is a wholly-owned subsidiary of Pasaca Capital (Pasadena, Calif.) IMG tactically pivoted and leveraged its knowledge in health care and medical devices to produce an environment to respond to the COVID-19 pandemic. The Innova Medical Community is delivering millions of tests every day to satisfy the varied, point-of-care requirements of the world’s federal governments, large corporations, and institutions. IMG uses a worldwide supply chain, including the innovative and respected companies of G.E. Health care (U.S.A.) and Sartorius (Germany). IMG protected unique production and distribution arrangements for its best-in-class portfolio of screening and diagnostic tests. For additional information, visit www.innovamedgroup.com. About Biological Lab, Inc.
Biological Lab, Inc(
BIOLAB)is a scientific lab that has actually been servicing the health care community given that 1998. BIOLAB is a certified facility and takes pride in offering the greatest quality of lab outcomes. The medical team is consisted of medical physicians, clinical lab researchers, bioanalysts, pathologists, microbiologists, and analytical chemists. In action to the COVID-19 pandemic, BIOLAB is offering testing throughout the United States. BIOLAB covers the complete spectrum of COVID-19 detection with services ranging from antibodies, antigen, and RT-PCR to keep communities safe. For additional information, please check out https://biolaboratory.net. For additional information on IMG’s COVID-19 environment or to order COVID-19 rapid diagnostic tests, contact [email secured] Associated Images image1.png SOURCE Innova Medical Group Inc.Associated Hyperlinks https://www.innovamedgroup.com/Source: prnewswire.com
Click to rate this post!
[Total: 0 Average: 0]